98
Participants
Start Date
March 31, 2008
Primary Completion Date
December 31, 2012
Study Completion Date
May 21, 2018
Chemotherapy
Up to 6 courses of investigator's choice of neoadjuvant, adjuvant, concurrent, or interdigitated chemotherapy
Radiation therapy
Preoperative IGRT (3D-CRT or IMRT): If receiving neoadjuvant or adjuvant chemotherapy or no chemotherapy: 50 Gy (2 Gy once a day, 5 times a week). If receiving concurrent or interdigitated chemotherapy: 44 Gy (2 Gy once a day, 5 times a week). Postoperative radiotherapy boost for patients with positive margins following surgery: 16 Gy (2 Gy once a day, 5 times a week) external beam radiation therapy or 16 Gy at ≤ 80 cGy per hour brachytherapy or 3.4 Gy/fraction in 4 fractions brachytherapy or 10-12.5 Gy in a single fraction intraoperative radiation therapy boost.
Surgery
Resection of the sarcoma with the goal of having negative pathologic margins. Every effort should be made to have limb preservation surgery unless there is documented evidence of tumor progression that would require amputation for an appropriate negative margin resection. All lesions of the extremities should be treated with wide excision.
CCOP - Christiana Care Health Services, Newark
Mayo Clinic - Jacksonville, Jacksonville
University of Miami Sylvester Comprehensive Cancer Center - Miami, Miami
Norton Suburban Hospital, Louisville
William Beaumont Hospital - Royal Oak Campus, Royal Oak
Medical College of Wisconsin Cancer Center, Milwaukee
Mayo Clinic Cancer Center, Rochester
University of Florida Shands Cancer Center, Gainesville
H. Lee Moffitt Cancer Center and Research Institute at University of South Florida, Tampa
Massachusetts General Hospital, Boston
Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon
Roswell Park Cancer Institute, Buffalo
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center, Hershey
Norris Cotton Cancer Center - North, Saint Johnsbury
Cross Cancer Institute at University of Alberta, Edmonton
London Regional Cancer Program at London Health Sciences Centre, London
McGill Cancer Centre at McGill University, Montreal
Collaborators (1)
National Cancer Institute (NCI)
NIH
NRG Oncology
OTHER
Radiation Therapy Oncology Group
NETWORK